B2M and colorectal carcinoma: We further verified the effects of drug resistance variants on B2M and HLA protein expression in HT-29 cells and a primary CRC organoid, CRC-9 (refs. 8,75,76) (Supplementary Note 4 and Extended Data Fig. 9a–d).